scholarly journals USABILITY AND PATIENT ACCEPTANCE OF PREFILLED OR REUSABLE INSULIN PENS

Author(s):  
Işılay KALAN SARI ◽  
Hüseyin DEMİRCİ
2008 ◽  
Vol 1 (4) ◽  
pp. 12
Author(s):  
MIRIAM E. TUCKER
Keyword(s):  

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 2281-PUB
Author(s):  
ANDREAS PFÜTZNER ◽  
RON NAGAR ◽  
WOLFGANG REEH
Keyword(s):  

Circulation ◽  
1995 ◽  
Vol 91 (11) ◽  
pp. 2753-2761 ◽  
Author(s):  
Keith D. Aaronson ◽  
J. Sanford Schwartz ◽  
James E. Goin ◽  
Donna M. Mancini

2015 ◽  
Vol 3 (6) ◽  
pp. 16-19
Author(s):  
Whitney B. Tooley ◽  
Lynn M. Fletcher ◽  
Jasmine D. Gonzalvo
Keyword(s):  

2021 ◽  
pp. 193229682098386 ◽  
Author(s):  
Lutz Heinemann ◽  
Oliver Schnell ◽  
Bernhard Gehr ◽  
Nanette C. Schloot ◽  
Sven W. Görgens ◽  
...  

Digital health management is increasingly pivotal in the care of patients with diabetes. The aim of this review was to evaluate the clinical benefits of using smart insulin pens with connectivity for diabetes management. The search was performed using PubMed and PubMed Central on May 15, 2019, to identify publications investigating the use of insulin pens. Studies evaluating insulin pens with connectivity via Bluetooth/Near Field Communication, with an associated electronic device enabling connectivity, or with a memory function were included in the review. Nine studies were identified in the search. Overall, these studies lacked data on smart insulin pens with a connectivity function, with eight of the available studies investigating only pens with a memory function. The studies focused primarily on assessing patient preference, usability, and technical accuracy. The number of studies assessing clinical outcomes was small ( n = 3). However, the majority of studies ( n = 8) reported that patients preferred smart insulin pens because they increased confidence with regard to diabetes self-management. These results suggest a lack of published data regarding smart insulin pens with connectivity for the management of diabetes. However, the available published data on usability and patient preference suggest that the use of smart insulin pens holds promise for improving and simplifying diabetes self-management.


2021 ◽  
pp. 193229682110025
Author(s):  
Urooj Najmi ◽  
Waqas Zia Haque ◽  
Umair Ansari ◽  
Eyerusalem Yemane ◽  
Lee Ann Alexander ◽  
...  

Background: Insulin pen injectors (“pens”) are intended to facilitate a patient’s self-administration of insulin and can be used in hospitalized patients as a learning opportunity. Unnecessary or duplicate dispensation of insulin pens is associated with increased healthcare costs. Methods: Inpatient dispensation of insulin pens in a 240-bed community hospital between July 2018 and July 2019 was analyzed. We calculated the percentage of insulin pens unnecessarily dispensed for patients who had the same type of insulin pen assigned. The estimated cost of insulin pen waste was calculated. A pharmacist-led task force group implemented hospital-wide awareness and collaborated with hospital leadership to define goals and interventions. Results: 9516 insulin pens were dispensed to 3121 patients. Of the pens dispensed, 6451 (68%) were insulin aspart and 3065 (32%) were glargine. Among patients on insulin aspart, an average of 2.2 aspart pens was dispensed per patient, but only an estimated 1.2 pens/patient were deemed necessary. Similarly, for inpatients prescribed glargine, an average of 2.1 pens/patient was dispensed, but only 1.3 pens/patient were necessary. A number of gaps were identified and interventions were undertaken to reduce insulin pen waste, which resulted in a significant decrease in both aspart (p = 0.0002) and glargine (p = 0.0005) pens/patient over time. Reductions in pen waste resulted in an estimated cost savings of $66 261 per year. Conclusions: In a community hospital setting, identification of causes leading to unnecessary insulin dispensation and implementation of hospital-wide staff education led to change in insulin pen dispensation practice. These changes translated into considerable cost savings and facilitated diabetes self-management education.


1980 ◽  
Vol 3 (3) ◽  
pp. 153-156 ◽  
Author(s):  
A. Vercellone ◽  
G.P. Segoloni ◽  
G. Triolo ◽  
C. Canavese ◽  
M. Messina

Dialysis is a method of treatment which in over 30 years of progress has developed different technologies and strategies now to be unified in a single dialytic culture. In our experience we have decided to adopt an open policy as for the patient acceptance and the setting of modes of therapy, taking in account 5 fundamental criteria: i.e. dialytic adequacy, rehabilitation, safety, economy and working simplicity. Today short dialysis is the backbone schedule we have developed with an intensive participation of the patients to their treatment. Yet our results are not only the expression of a schedule but also a demonstration of how valuable may result some cautions in the management of the RDT patient.


Pharmaceutics ◽  
2021 ◽  
Vol 13 (8) ◽  
pp. 1187
Author(s):  
Nayla Francine Garcia Pastório ◽  
Camila Felix Vecchi ◽  
Rafaela Said dos Santos ◽  
Marcos Luciano Bruschi

Tramadol hydrochloride is a synthetic analogue of codeine and shows activity on the central nervous system as an opioid agonist and inhibitor of serotonin and norepinephrine reuptake. It has been used for controlling moderate to severe pain. Mucoadhesive fast-dissolving films can present greater drug availability and patient acceptance when compared to the systems of peroral administration. The films were prepared using the solvent casting method with ethylcellulose, polyvinylpyrrolidone and poly(vinyl alcohol). The effect of each polymer concentration was investigated using a 2³ factorial design with repetition at the central point. The formulations were subjected to physicochemical, mechanical, ex vivo mucoadhesive and in vitro drug release profile analysis. These properties were dependent on the polymeric composition (independent factors) of each system. The optimized formulations showed good macroscopic characteristics, improved resistance to bending, rigidity, rapid swelling up to 60 s, improved mechanical and mucoadhesive characteristics, and also fast dissolving and tramadol release. The optimized formulations constitute platforms and strategies to improve the therapy of tramadol with regard to availability at the site of application, considering the necessity of rapid pain relief, and show potential for in vivo evaluation.


Sign in / Sign up

Export Citation Format

Share Document